Dijon Stroke Cohort

CVA, Dijon Registry Clinical Trial

— DISCO  

Official title:

Dijon Stroke Cohort

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04489199
• Other study ID #: BEJOT 2020
• Status: Recruiting
• Start date: January 1, 2021
• Est. completion date: January 2040

Study information

• Verified date: February 2024
• Source: Centre Hospitalier Universitaire Dijon
• Contact: Yannick BEJOT
• Phone: 03.80.29.37.53
• Email: yannick.bejo[@]chu-dijon.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The Dijon Stroke Registry, accredited by the Registry Evaluation Committee, INSERM and Public Health France, has been studying the epidemiology of cerebrovascular accidents (cerebral infarction, intracerebral haemorrhages, meningeal haemorrhages) and transient ischaemic attacks (TIAs) within the city of Dijon since 1985.

As a result of the development of therapies for acute disease, the prognosis of patients has improved over time. Thus, the number of stroke survivors has increased by 90% between the 1980s and today. This raises new issues: risk of vascular recurrence, drug iatrogeny, and functional impact of stroke for motor, cognitive or thymic function. In the absence of available data in France, the investigators wish to set up an extended cohort follow-up of patients in order to study their long-term prognosis and to study the impact of future therapies on the evolutionary course of the disease.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 4000
• Est. completion date: January 2040
• Est. primary completion date: January 2040
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patients included in the Dijon Stroke Registry and not opposed to participating

Exclusion Criteria:

• minor patients; opposition to participation

Related Conditions & MeSH terms

• CVA, Dijon Registry

Intervention

Other:
• Questionnaire and semi-structured interview
questionnaire submitted by telephone 3 months, 6 months, 1 year, 5 years, and 10 years after the stroke/TIA. interview duration 20 to 40 minutes

Locations

Country	Name	City	State
France	Chu Dijon Bourgogne	Dijon

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire Dijon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Death rate		Trough study completion, an average of 10 years
Primary	Disability rate		Trough study completion, an average of 10 years
Primary	Quality of Life Questionnaire		Trough study completion, an average of 10 years
Primary	Neuropsychological questionnaire		Trough study completion, an average of 10 years